Does the use of cholinesterase inhibitors, particularly donepezil and galantamine, reduce all-cause mortality

/Does the use of cholinesterase inhibitors, particularly donepezil and galantamine, reduce all-cause mortality in patients with diabetes mellitus and dementia?

Research Question

Does the use of cholinesterase inhibitors, particularly donepezil and galantamine, reduce all-cause mortality in patients with diabetes mellitus and dementia?

2026